Your browser doesn't support javascript.
loading
Haploinsufficiency in tumor predisposition syndromes: altered genomic transcription in morphologically normal cells heterozygous for VHL or TSC mutation.
Peri, Suraj; Caretti, Elena; Tricarico, Rossella; Devarajan, Karthik; Cheung, Mitchell; Sementino, Eleonora; Menges, Craig W; Nicolas, Emmanuelle; Vanderveer, Lisa A; Howard, Sharon; Conrad, Peggy; Crowell, James A; Campbell, Kerry S; Ross, Eric A; Godwin, Andrew K; Yeung, Anthony T; Clapper, Margie L; Uzzo, Robert G; Henske, Elizabeth P; Ricketts, Christopher J; Vocke, Cathy D; Linehan, W Marston; Testa, Joseph R; Bellacosa, Alfonso; Kopelovich, Levy; Knudson, Alfred G.
Afiliação
  • Peri S; Department of Biostatistics and Bioinformatics, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Caretti E; Cancer Epigenetics, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Tricarico R; Cancer Epigenetics, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Devarajan K; Department of Biostatistics and Bioinformatics, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Cheung M; Cancer Biology, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Sementino E; Cancer Biology, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Menges CW; Cancer Biology, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Nicolas E; Cancer Biology, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Vanderveer LA; Cancer Prevention and Control, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Howard S; Blood Cell Development and Function, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Conrad P; University of California San Francisco, San Francisco, CA, USA.
  • Crowell JA; Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, NCI, Rockville, MD, USA.
  • Campbell KS; Blood Cell Development and Function, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Ross EA; Department of Biostatistics and Bioinformatics, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Godwin AK; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA.
  • Yeung AT; Cancer Prevention and Control, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Clapper ML; Cancer Prevention and Control, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Uzzo RG; Cancer Biology, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Henske EP; Kidney Cancer Programs, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Ricketts CJ; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, NCI, Bethesda, MD, USA.
  • Vocke CD; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute Bethesda, MD, USA.
  • Linehan WM; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute Bethesda, MD, USA.
  • Testa JR; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute Bethesda, MD, USA.
  • Bellacosa A; Cancer Biology, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Kopelovich L; Kidney Cancer Programs, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Knudson AG; Cancer Epigenetics, Fox Chase Cancer Center, Philadelphia, PA, USA.
Oncotarget ; 8(11): 17628-17642, 2017 Mar 14.
Article em En | MEDLINE | ID: mdl-27682873
ABSTRACT
Tumor suppressor genes and their effector pathways have been identified for many dominantly heritable cancers, enabling efforts to intervene early in the course of disease. Our approach on the subject of early intervention was to investigate gene expression patterns of morphologically normal "one-hit" cells before they become hemizygous or homozygous for the inherited mutant gene which is usually required for tumor formation. Here, we studied histologically non-transformed renal epithelial cells from patients with inherited disorders that predispose to renal tumors, including von Hippel-Lindau (VHL) disease and Tuberous Sclerosis (TSC). As controls, we studied histologically normal cells from non-cancerous renal epithelium of patients with sporadic clear cell renal cell carcinoma (ccRCC). Gene expression analyses of VHLmut/wt or TSC1/2mut/wt versus wild-type (WT) cells revealed transcriptomic alterations previously implicated in the transition to precancerous renal lesions. For example, the gene expression changes in VHLmut/wt cells were consistent with activation of the hypoxia response, associated, in part, with the "Warburg effect". Knockdown of any remaining VHL mRNA using shRNA induced secondary expression changes, such as activation of NFκB and interferon pathways, that are fundamentally important in the development of RCC. We posit that this is a general pattern of hereditary cancer predisposition, wherein haploinsufficiency for VHL or TSC1/2, or potentially other tumor susceptibility genes, is sufficient to promote development of early lesions, while cancer results from inactivation of the remaining normal allele. The gene expression changes identified here are related to the metabolic basis of renal cancer and may constitute suitable targets for early intervention.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas de Ligação ao Cálcio / Predisposição Genética para Doença / Proteína Supressora de Tumor Von Hippel-Lindau Limite: Humans Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas de Ligação ao Cálcio / Predisposição Genética para Doença / Proteína Supressora de Tumor Von Hippel-Lindau Limite: Humans Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos